Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Lisuride, sold under the brand name Dopergin among others, is a monoaminergic medication of the ergoline family which is used in the treatment of Parkinson's disease, migraine, and high prolactin levels. It is taken by mouth.
The analysis highlights History, Community, Culture and Applications as prominent areas in the source structure around Lisuride.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Lisuride shows recurring relationship patterns in the source. For example, Lisuride → Accordingly, Alternatively, D1, D2, D3, D4, D5, Due, GPCR, Gq, H1, However, HT1A, HT1B, HT1D, HT2A, HT2B, HT2C, HT5A, It Another extracted example is Lisuride → Arolac, Cuvalit, Dopagon, Dopergin, Dopergine, Eunal, Lisenil, Lizenil, Lysenyl, Proclacam, Prolacam, Revanil. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
5-ht2a serotonin receptor effects receptors dopamine lsd agonist may parkinson's disease side prolactin doses treatment psychedelic hallucinogenic antagonist high levels
TTTA extracted 114 structured relationships around Lisuride. Examples in this analysis include Lisuride → 3D model (JSmol) → Interactive image and Lisuride → AHFS/Drugs.com → International Drug Names. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Lisuride | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Lisuride | AHFS/Drugs.com | International Drug Names | 1.00 | infobox |
| Lisuride | ATC code | G02CB02 (WHO) N02CA07 (WHO) | 1.00 | infobox |
| Lisuride | Bioavailability | 10–20% | 1.00 | infobox |
| Lisuride | CAS Number | 18016-80-3 Y | 1.00 | infobox |
| Lisuride | ChEBI | CHEBI:51164 Y | 1.00 | infobox |
| Lisuride | ChEMBL | ChEMBL157138 Y | 1.00 | infobox |
| Lisuride | ChemSpider | 26847 Y | 1.00 | infobox |
| Lisuride | CompTox Dashboard (EPA) | DTXSID30274075 DTXSID3023217, DTXSID30274075 | 1.00 | infobox |
| Lisuride | Drug class | Serotonin receptor agonist; Dopamine receptor agonist | 1.00 | infobox |
| Lisuride | DrugBank | DB00589 Y | 1.00 | infobox |
| Lisuride | ECHA InfoCard | 100.038.099 | 1.00 | infobox |
| Lisuride | Elimination half-life | 2 hours | 1.00 | infobox |
| Lisuride | Excretion | Renal and biliary in equal amounts | 1.00 | infobox |
| Lisuride | Formula | C20H26N4O | 1.00 | infobox |
| Lisuride | IUPHAR/BPS | 43 | 1.00 | infobox |
| Lisuride | KEGG | D08132 Y | 1.00 | infobox |
| Lisuride | Legal status | BR: Class C1 (Other controlled substances) | 1.00 | infobox |
| Lisuride | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Lisuride | Metabolism | Hepatic | 1.00 | infobox |
| Lisuride | Metabolites | More than 15 known | 1.00 | infobox |
| Lisuride | Molar mass | 338.455 g·mol−1 | 1.00 | infobox |
| Lisuride | Other names | Lysuride; Mesorgydin; Methylergol carbamide; 1,1-Diethyl-3-(6-methyl-9,10-didehydroergolin-8α-yl)urea | 1.00 | infobox |
| Lisuride | Protein binding | 60–70% | 1.00 | infobox |
| Lisuride | PubChem CID | 28864 | 1.00 | infobox |
| Lisuride | Routes of administration | Oral Investigational: Subcutaneous implant, transdermal patch | 1.00 | infobox |
| Lisuride | Trade names | Dopergin, others | 1.00 | infobox |
| Lisuride | UNII | E0QN3D755O | 1.00 | infobox |
| Lisuride | is a | partial agonist of the D2 | 0.90 | text |
| Lisuride | is a | extremely potent serotonin 5-HT1A receptor agonist | 0.90 | text |
The concept neighborhoods around Lisuride bring nearby vocabulary together. In this analysis, examples include Receptor, Serotonin and Effects. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Lisuride, one of the stronger structural bridges in this analysis connects Lisuride with Pharmacology. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Lisuride to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Community, Culture & Applications, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Lisuride · EN edition · Analysis: TopicsToTalkAbout